Cargando…
Hyper IgE syndrome‐related disease treated with dupilumab: A case report
Phosphoglucomutase 3 (PGM3) catalyzes the glycosylation of immune system precursor proteins. Its impairment leads to severe infections and other developmental, musculoskeletal, and nervous system defects. We present a case of a 2‐month‐old female patient with recurrent infections and diffuse eczemat...
Autores principales: | Kao, Andrew S., Deirawan, Hany, Poowuttikul, Pavadee, Daveluy, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500051/ https://www.ncbi.nlm.nih.gov/pubmed/37720709 http://dx.doi.org/10.1002/ccr3.7614 |
Ejemplares similares
-
Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab
por: Nihal, Aman, et al.
Publicado: (2022) -
Hyper IgE syndrome
por: Dang, Yun, et al.
Publicado: (2014) -
An update on the hyper-IgE syndromes
por: Yong, Patrick FK, et al.
Publicado: (2012) -
Clinical Manifestations of Hyper IgE Syndromes
por: Freeman, Alexandra F., et al.
Publicado: (2010) -
HYPER IgE SYNDROME WITH UMBILICAL HERNIA
por: Hiremath, N C, et al.
Publicado: (2009)